BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36988891)

  • 21. Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression.
    Wang S; Zhang Y; Cai Q; Ma M; Jin LY; Weng M; Zhou D; Tang Z; Wang JD; Quan Z
    Mol Cancer; 2019 Oct; 18(1):145. PubMed ID: 31623628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
    Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancer.
    Zhang Y; Li H; Lv C; Wu B; Yu Y; Zhong C; Lang Q; Liang Z; Li Y; Shi Y; Zhang J; Xu F; Tian Y
    Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35920182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E26 transformation (ETS)‑specific related transcription factor‑3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer.
    Chen H; Chen W; Zhang X; Hu L; Tang G; Kong J; Wang Z
    Oncol Rep; 2019 Jan; 41(1):570-578. PubMed ID: 30365150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
    Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
    Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribonucleotide reductase subunit M1 is a possible chemoresistance marker to gemcitabine in biliary tract carcinoma.
    Ohtaka K; Kohya N; Sato K; Kitajima Y; Ide T; Mitsuno M; Miyazaki K
    Oncol Rep; 2008 Aug; 20(2):279-86. PubMed ID: 18636187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
    He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
    Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer.
    Wang H; Zhan M; Xu SW; Chen W; Long MM; Shi YH; Liu Q; Mohan M; Wang J
    Cell Death Dis; 2017 May; 8(5):e2770. PubMed ID: 28492560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PLAC8 overexpression correlates with PD-L1 upregulation and acquired resistance to chemotherapies in gallbladder carcinoma.
    Gong K; Gong ZJ; Lu PX; Ni XL; Shen S; Liu H; Wang JW; Zhang DX; Liu HB; Suo T
    Biochem Biophys Res Commun; 2019 Aug; 516(3):983-990. PubMed ID: 31272718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.
    Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B
    Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomal long non-coding RNA TRPM2-AS promotes angiogenesis in gallbladder cancer through interacting with PABPC1 to activate NOTCH1 signaling pathway.
    He Z; Zhong Y; Regmi P; Lv T; Ma W; Wang J; Liu F; Yang S; Zhong Y; Zhou R; Jin Y; Cheng N; Shi Y; Hu H; Li F
    Mol Cancer; 2024 Mar; 23(1):65. PubMed ID: 38532427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-197 promotes proliferation and inhibits apoptosis of gallbladder cancer cells by targeting insulin-like growth factor-binding protein 3.
    Tong L; Cheng J; Zuo H; Li J
    Adv Clin Exp Med; 2021 Jul; 30(7):661-672. PubMed ID: 34118139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of NDRG2 promotes epithelial-mesenchymal transition of gallbladder carcinoma cells through MMP-19-mediated Slug expression.
    Lee DG; Lee SH; Kim JS; Park J; Cho YL; Kim KS; Jo DY; Song IC; Kim N; Yun HJ; Park YJ; Lee SJ; Lee HG; Bae KH; Lee SC; Shim S; Kim YM; Kwon YG; Kim JM; Lee HJ; Min JK
    J Hepatol; 2015 Dec; 63(6):1429-39. PubMed ID: 26292259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-193a-3p Enhanced the Chemosensitivity to Trametinib in Gallbladder Carcinoma by Targeting KRAS and Downregulating ERK Signaling.
    Yang G; Xu Q; Wan Y; Zhang L; Wang Z; Meng F
    Cancer Biother Radiopharm; 2023 Aug; 38(6):371-379. PubMed ID: 34287012
    [No Abstract]   [Full Text] [Related]  

  • 35. E74-Like Factor 3 Is a Key Regulator of Epithelial Integrity and Immune Response Genes in Biliary Tract Cancer.
    Suzuki M; Saito-Adachi M; Arai Y; Fujiwara Y; Takai E; Shibata S; Seki M; Rokutan H; Maeda D; Horie M; Suzuki Y; Shibata T; Kiyono T; Yachida S
    Cancer Res; 2021 Jan; 81(2):489-500. PubMed ID: 33293429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathway.
    Yang L; Gao Q; Wu X; Feng F; Xu K
    J Exp Clin Cancer Res; 2018 Aug; 37(1):186. PubMed ID: 30086773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topoisomerase II alpha promotes gallbladder cancer proliferation and metastasis through activating phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway.
    Lyu WJ; Shu YJ; Liu YB; Dong P
    Chin Med J (Engl); 2020 Oct; 133(19):2321-2329. PubMed ID: 32925281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo.
    Qin Y; Zhou Y; Ge A; Chang L; Shi H; Fu Y; Luo Q
    Biomed Pharmacother; 2019 Oct; 118():109266. PubMed ID: 31401397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LINC00472 suppresses oral squamous cell carcinoma growth by targeting miR-455-3p/ELF3 axis.
    Liu X; Ma X; Li H; Wang Y; Mao M; Liang C; Hu Y
    Bioengineered; 2022 Jan; 13(1):1162-1173. PubMed ID: 35258410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcription factor E2F7 activates PKMYT1 to partially suppress adriamycin sensitivity in gastric cancer through the MAPK signaling pathway.
    Yang X; Zeng J; Jiang C; Zhang Y; Zhang X
    Rev Invest Clin; 2024 Mar; 76(1):6-17. PubMed ID: 38253021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.